Oxidative mechanisms and atherothrombotic cardiovascular disease

Drug Discovery Today: Therapeutic Strategies

Volumn 5, Issue 1, 2008, Pages 5-13

  Leopold, Jane A ^a   Loscalzo, Joseph ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL RESPIRATION; CHOLESTEROL BLOOD LEVEL; FOAM CELL; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; LIPID OXIDATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 57249084269     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2008.02.001     Document Type: Review

References (46)

1. Association A.H. (2007) International Cardiovascular Disease Statistics
2. Yung L.M., et al. Reactive oxygen species in vascular wall. Cardiovasc. Hematol. Disord. Drug Targets 6 (2006) 1-19
3. Sorescu D., et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105 (2002) 1429-1435
4. Azumi H., et al. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 22 (2002) 1838-1844
5. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
6. Turrens J.F., and Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191 (1980) 421-427
7. Griendling K.K., et al. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
8. Jarasch E.D., et al. Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 25 (1981) 67-82
9. Romano M., and Claria J. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 17 (2003) 1986-1995
10. Vasquez-Vivar J., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9220-9225
11. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 273 (1998) 25804-25808
12. Leopold J.A., and Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1332-1340
13. Madamanchi N.R., et al. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 29-38
14. Stocker R., and Keaney Jr. J.F. New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 3 (2005) 1825-1834
15. Ross R., and Glomset J.A. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180 (1973) 1332-1339
16. Steinberg D., et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl J. Med. 320 (1989) 915-924
17. Goldstein J.L., et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 333-337
18. Hazell L.J., and Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J. 290 Pt 1 (1993) 165-172
19. Vohra R.S., et al. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor. Trends Cardiovasc. Med. 16 (2006) 60-64
20. Nakajima K., et al. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin. Chim. Acta 367 (2006) 36-47
21. Tsimikas S., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N. Engl. J. Med. 353 (2005) 46-57
22. Ansell B.J., et al. The paradox of dysfunctional high-density lipoprotein. Curr. Opin. Lipidol. 18 (2007) 427-434
23. Ansell B.J., et al. High-density lipoprotein function recent advances. J. Am. Coll. Cardiol. 46 (2005) 1792-1798
24. Brewer Jr. H.B. High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 387-391
25. Hedrick C.C., et al. Glycation impairs high-density lipoprotein function. Diabetologia 43 (2000) 312-320
26. Rohrer L., et al. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr. Opin. Lipidol. 15 (2004) 269-278
27. Ansell B.J., et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108 (2003) 2751-2756
28. Gowri M.S., et al. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2226-2233
29. Hansson G.K. Vaccination against atherosclerosis: science or fiction?. Circulation 106 (2002) 1599-1601
30. Hansson G.K., et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91 (2002) 281-291
31. Nilsson J., et al. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 18-28
32. Nicoletti A., et al. Immunomodulation of atherosclerosis: myth and reality. J. Intern. Med. 247 (2000) 397-405
33. Azenabor A.A., et al. Macrophage antioxidant enzymes regulate Chlamydia pneumoniae chronicity: evidence of the effect of redox balance on host-pathogen relationship. Immunobiology 211 (2006) 325-339
34. Salmen S., et al. CD40/CD40L expression in leukocytes from chronic granulomatous disease patients. Apmis 115 (2007) 939-947
35. Griffiths H.R. ROS as signalling molecules in T cells - evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep. 10 (2005) 273-280
36. Lehoux S. Redox signalling in vascular responses to shear and stretch. Cardiovasc. Res. 71 (2006) 269-279
37. De Keulenaer G.W., et al. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ. Res. 82 (1998) 1094-1101
38. Hsieh H.J., et al. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J. Cell Physiol. 175 (1998) 156-162
39. Hwang J., et al. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ. Res. 93 (2003) 1225-1232
40. McNally J.S., et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2290-H2297
41. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ. Res. 93 (2003) 573-580
42. Malek A.M., et al. Hemodynamic shear stress and its role in atherosclerosis. JAMA 282 (1999) 2035-2042
43. Walpola P.L., et al. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 2-10
44. O'Leary D.H., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340 (1999) 14-22
45. Buemi M., et al. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. Hypertension 30 (1997) 845-847
46. Cheng J.J., et al. Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension 31 (1998) 125-130